HIMSSCast: The hurdles of AI in the pharma industry
“As seen on Healthcare Finance News” Pharma faces regulations and stringent rules for transparency, but the payoff is drugs that can get to market faster and possibly at less expense. Pharma first started using artificial intelligence in the clinical and development space, but over the last two years, the industry has expanded its use, according […]
New York Stock Exchange Spotlights Impiricus for Unprecedented Impact for Physicians and Pharma
NEW YORK, NY — December 22, 2025 — Impiricus, the leading AI-powered physician engagement platform, was honored this week by the New York Stock Exchange (NYSE) with a featured spotlight on the trading floor. The recognition celebrates the company’s unprecedented 30,000% growth over the past several years and its expanding influence in life sciences. The […]
Nasdaq Celebrates Impiricus for 30,000% Growth and AI Innovation in Healthcare
NEW YORK, NY — On December 15, 2025, Impiricus, a leader in AI-powered healthcare engagement, was spotlighted on the iconic Nasdaq Tower in Times Square. The feature marks a historic milestone for the company, celebrating its unprecedented 30,000% growth over the last few years and its role as the new standard-bearer for ethical AI in […]
Mike Gelber, Chief Product Officer at Impiricus, Named to MM+M’s 40 Under 40 List
NEW YORK, NY – December 4, 2025 – MM+M has announced its seventh class of 40 Under 40 honorees, recognizing Mike Gelber, Chief Product Officer at Impiricus, the #1 fastest growing company in North America according to Deloitte. Gelber is honored for pioneering the future of ethical physician-pharma collaboration through the launch of Impiricus Ascend, […]
Deloitte Unveils 2025 North America Technology Fast 500™ Rankings
NEW YORK, Nov. 19, 2025 /PRNewswire/ — Deloitte today released its “North America Technology Fast 500™, an annual ranking of the fastest-growing North American companies in the technology, media, telecommunications, life sciences, fintech, and energy tech sectors, now in its 31st year. Technology Fast 500 awardees are selected based on percentage fiscal year revenue growth from 2021 to 2024. […]
Impiricus Launches Ascend, An AI Platform To Ethically Connect Physicians And Pharma
Today’s healthcare environment is marked by rapid drug advancements, evolving patient expectations, and increasing pressures on healthcare professionals (HCPs) to deliver high-quality care.
Beyond the Molecule: Supporting Oncologists and Patients in the Age of AI
Today’s healthcare environment is marked by rapid drug advancements, evolving patient expectations, and increasing pressures on healthcare professionals (HCPs) to deliver high-quality care.
From Noise to Value: Ending Content Overload for Physicians
As seen in Medical Expo How Ethical AI Can Transform Clinical Decision-Making and Restore Trust in Healthcare Engagement Physicians today face a paradox: they are surrounded by more medical information than ever, yet often struggle to access the pertinent insights they need, when they need them. From clinical guidelines and journal articles to EHR alerts […]
What banning direct-to-consumer pharma ads would mean for doctors
As seen in Medical Economics When U.S. Health and Human Services Secretary Robert F. Kennedy Jr. signaled support for curbing or ending direct-to-consumer (DTC) prescription drug advertising, and senators introduced a bill to prohibit it, the policy debate suddenly felt very close to the exam room. Our thesis is straightforward: a ban would not quiet pharmaceutical ad promotion so much […]
What the FDA’s DTC drug ad crackdown means for pharma companies
As seen in TechTarget As the FDA and HHS rein in direct-to-consumer drug advertising, new compliance rules and AI-driven monitoring could require some pharma companies to rethink their marketing approach. President Trump signed a memorandum, on Sept. 9, directing HHS, “to ensure transparency and accuracy in direct-to-consumer prescription drug advertising including by increasing the amount of information […]